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Our previous study demonstrated that the inhibition of
interleukin-1 (IL-1) reduces ischemic brain injury; how-
ever, the molecular mechanism of the action of IL-1 in
cerebral ischemia is unclear. We are investigating cur-
rently the role of NFB during focal cerebral ischemia,
using mutant mice deficient in the interleukin-1 convert-
ing enzyme gene (ICE KO) in a middle cerebral artery
occlusion (MCAO) model. Adult male ICE KO and wild-
type mice (n  120) underwent up to 24 hr of permanent
MCAO. Cytoplasmic phospho-NFB/p65 expression in
ischemic brain was examined using Western blot analy-
sis and immunohistochemistry. NFB DNA-binding ac-
tivity was detected using electrophoretic mobility shift
assay (EMSA). Furthermore, ICAM-1 expression was ex-
amined in both the ICE KO and wild-type mice (WT).
Western blot analysis and immunostaining showed that
the level of cytosolic phosphorylated NFB/p65 in-
creased after 2 and 4 hr of MCAO in WT mice; however,
NFB/p65 was significantly reduced after MCAO in the
ICE KO mice (P  0.05). EMSA showed that NFB DNA-
binding activity increased after MCAO in WT mice; but
this effect was reduced in the ICE KO mice. The number
of ICAM-1-positive vessels in the ischemic hemisphere
was greatly attenuated in the ICE KO mice (P  0.05),
which paralleled the results of immunohistochemistry.
Our results demonstrate that NFB phosphorylation is
reduced in ICE KO mice, suggesting that ICE or IL-1 are
involved in early NFB phosphorylation. Because cere-
bral ischemia induced infarction is significantly reduced
in ICE KO mice, we conclude that early NFB phosphor-
ylation plays a disruptive role in the ischemic process.
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Cerebral ischemia activates a cascade of intracellular
signal transduction pathways through the production of
many different stimuli, including proinflammatory cyto-
kines, reactive oxygen species (ROS), neurotrophic fac-
tors, and calcium influx (Mattson, 1997). It is well known
that proinflammatory cytokines play an important role in
the pathogenesis of cerebral ischemia (Dinarello, 1997b).
Interleukin-1 (IL-1), a proinflammatory cytokine, is
increased markedly during global and focal cerebral isch-
emia and postischemic reperfusion (Rothwell and Hop-
kins, 1995; Szaflarski et al., 1995; Arvin et al., 1996).
Exogenous application of IL-1 exacerbates ischemic
brain injury, whereas administration or overexpression of
IL-1 receptor antagonist (IL-1ra) greatly reduces ischemic
brain injury (Minami et al., 1992; Yamasaki et al., 1992,
1996; Betz et al., 1995; Loddick and Rothwell, 1996;
Feuerstein et al., 1997). IL-1 -converting enzyme (ICE)
cleaves inactive 31-kD pro-IL-1 to the active 17-kD
IL-1 form and processes the pro-interferon -inducing
factor. ICE is a member of a family of cysteine proteases,
the caspases, several of which are associated with the
apoptotic cell death pathway. This pathway has been
implicated in ischemic brain damage (Linnik et al., 1993).
Our previous studies have demonstrated that ischemic
brain injury, edema formation, and inflammatory re-
sponses were reduced significantly in ICE knockout (ICE
KO) mice (Schielke et al., 1998; Yang et al., 1999c). It is
uncertain, however, whether ICE-deficient mice are pro-
tected from ischemic damage by a reduction of inflamma-
tory response, apoptosis, or both (Hara et al., 1997b;
Schielke et al., 1998).
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Responses to a variety of stimuli associated with
stress and injury such as ischemia are mediated through
numerous intracellular signaling molecules(Carroll et al.,
2000). An important signaling molecule among them is
nuclear transcription factor kappa B (NFB), which is
activated by cytokines, mitogens, physical or oxidative
stress, and chemical agents (Siebenlist et al., 1994). Potent
inducers of NFB include cytokines, tumor necrosis
factor-alpha (TNF), IL-1, lipopolysaccharide, oxygen
free radicals, ultraviolet light, and -irradiation (Baeuerle
and Baichwal, 1997). NFB is classified as a Rel protein
and is distinguished structurally by a Rel homology do-
main that is involved in DNA binding and dimerization
(Verma et al., 1995). NFB is composed normally of a
dimer of 50- and 65-kD subunits that reside in the cyto-
plasm of most cells and are bound to an inhibitory protein,
I kappa B (IB). Upon exposure to stimuli, IB protein is
phosphorylated, followed by ubiquitination and degrada-
tion. As a consequence, NFB is phosphorylated and
translocated into the nucleus, where it initiates gene tran-
scription. It is known that phospho-NFB participates in
the control of transcription of over 150 target genes,
including proinflammatory cytokines, chemokines, im-
munoreceptors, acute phase proteins, stress response genes,
and regulators of apoptosis (Gilmore et al., 1996; Gilmore,
1997).
To identify the relationship between decreased levels
of ICE and the phosphorylation of NFB, we designed
the present experiments to determine the levels of
phospho-NFB after middle cerebral artery occlusion
(MCAO) in mutant mice deficient in the ICE gene.
Furthermore, we examined the role of NFB in regulating
the inflammatory response during focal cerebral ischemia.
MATERIALS AND METHODS
Animal Preparation
The institutional animal care and use committee approved
the procedures for the use of laboratory animals. The ICE KO
mice were developed and characterized by the BASF Corpora-
tion, (Worcester, MA) (Li et al., 1995). These mice contain a
null mutation in the ICE gene (ICE/) generated by homol-
ogous recombination in embryonic stem cells. The wild-type
(WT, ICE/) mice were generated from the same chimeric
founder, and interbred amongst themselves. Both strains have a
mixed background of SV129- and C57BL/6-derived genes.
Experimental Groups
Three separate paradigms were used in this study. The first
experiment measured the time course of NFB expression after
MCAO using Western blot analysis. Adult ICE KO (n  20)
and WT mice (n  20) weighing 28–35 g underwent 0.5, 2, 4,
8, and 24 hr of permanent MCAO (n  4 at each point). The
second experiment localized NFB and intercellular adhesion
molecule-1 (ICAM-1) expression using double-labeled fluores-
cence staining or stable 3,3	-diaminobenzidine tetrahydrochlo-
ride (DAB; Research Genetics, Huntsville, AL) immunostain-
ing. ICE KO (n  20) and WT mice (n  20) underwent 0, 2,
4, 8, and 24 hr of permanent MCAO (n  4 at each time point).
The third experiment examined the NFB activity using elec-
trophoretic mobility gel-shift assay (EMSA). The time points
and animal numbers were the same as Experiment 1 and 2.
Middle Cerebral Artery Occlusion
Adult ICE KO and WT mice were anesthetized with 4%
isoflurane in 70% N2O/30% O2 and maintained with 1.5%
isoflurane through a facemask. Body temperature was main-
tained with a heated blanket using a feedback control system
(73A, Yellow Springs, Ohio). MCAO was carried out as de-
scribed previously (Yang et al., 1994). Briefly, the left common
carotid artery was exposed through a midline incision. The
internal carotid artery was isolated and the pterygopalatine
branch ligated close to its origin. A 2-cm length of 5-0 rounded
tip nylon suture was gently advanced from the external carotid
artery through the common carotid artery and into the internal
carotid artery for a distance of 11.0 
 0.5 mm.
Surface Cerebral Blood Flow Measurement
Surface cerebral blood flow (sCBF) was measured using a
laser-Doppler flowmetry monitor (Model BPM2 System; Vasa-
medics, St. Paul, MN) equipped with a small caliber probe of
0.7-mm diameter (P-433; Vasamedics). Surface CBF was mea-
sured 5 min before and 15 min after MCAO at three points: 1)
the ischemic core: 3.5 mm lateral and 1 mm posterior to the
bregma on the ipsilateral hemisphere; 2) the control area: cor-
responding site on the contralateral hemisphere; and 3) the
perifocal area: 1 mm lateral and 1 mm posterior to the bregma
on the ipsilateral hemisphere. Blood flow values are expressed as
a percentage of baseline values (Yang et al., 1997).
Western Blot Analysis
Mice were sacrificed at 0.5, 2, 4, 8, and 24 hr of MCAO.
The brains were removed immediately and divided into con-
tralateral and ipsilateral hemispheres. Tissue samples were ho-
mogenized and lysed in a buffer containing 150 mM NaCl,
50 mM Tris-Cl, 1% NP-40, 0.5% DOC, 0.1% sodium dodecyl
sulfate (SDS), and 100 g/ml polymethylsulfonylfluoride, as
well as 2 g/ml each of pepstatin, leupeptin, and chymostatin.
Lysates were cleared by centrifugation at 14,000  g for 10 min
at 4°C. The protein concentration of each sample was deter-
mined with a Bio-Rad assay (Bio-Rad, Hercules, CA). Western
blot analysis was carried out using standard techniques (Sam-
brook et al., 1989). The sample was boiled at 100°C in SDS gel
loading buffer (100 mM Tris-Cl, 4% SDS, 0.2% bromophenol
blue, and 20% glycerol) for 5 min. The protein sample was
loaded onto a 7.5% SDS polyacrylamide gel. After electrophore-
sis, size-fractionated proteins were electrotransferred to a poly-
vinylidene difluoride membrane (PVDF; Bio-Rad Laboratories,
Hercules, CA) in a transfer buffer. The membrane was placed in
5% powdered milk in 100 mM phosphate-buffered saline (PBS)
solution with 0.1% Tween 20 (PBST) for 60 min at room
temperature to block nonspecific binding. The transferred
PVDF membrane was probed with polyclonal goat anti-activate
NFB/p65 antibody (1:500 dilution; Santa Cruz Biotechnol-
ogy, Santa Cruz, CA) in blocking buffer overnight at 4°C. After
washing, the membrane was immunoprobed with peroxidase-
conjugated anti-goat IgG-HRP (1:2,000 dilution; Santa Cruz
Biotechnology). An enhanced ECL kit (Amersham, Bucking-
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hamshire, UK) was applied to detect the active NFB protein
according to the manufacturer’s instructions. Protein amount
was quantified by a gel densitometric scanning program using
NIH 1.62 image software.
Immunohistochemistry
ICE KO and WT mice were anesthetized and perfused
transcardially with heparinized saline, followed by 2% parafor-
maldehyde in 100 mM PBS, pH 7.4 (Sigma, St. Louis, MO),
after 0.5, 2, 4, 8, and 24 hr of MCAO. Brains were removed,
postfixed overnight in the same solution, immersed in 25%
sucrose at 4°C until they sunk to the bottom, and then embed-
ded in a 60%/40% sucrose/OCT (Sakura Finetek, Torrance,
CA) solution. Coronal sections (20 m in thickness) were cut
on a cryostat (CM1800; Leica, Germany) and mounted on
precleaned microscope slides (Fisher Scientific, Pittsburgh, PA).
For single NFB/p65 immunohistochemistry, sections were
incubated for 30 min with 10% goat serum to reduce nonspe-
cific binding. Sections were then washed in PBST (PBS con-
taining 0.5% Triton X-100) and incubated overnight at 4°C
with a rabbit polyclonal anti-active NFB/p65 antibody (1:500
dilution; Santa Cruz Biotechnology). Negative controls were
carried out using the same concentration of normal rabbit IgG
instead of primary antibody. After treatment with 1% H2O2 in
30%/70% methanol/PBS solution, the sections were incubated
with a biotinylated goat anti-rabbit secondary antibody in 1:200
dilution for 90 min at room temperature, followed by an ABC
process (ABC-Elite Kit; Vector, San Francisco, CA). Finally, the
sections were treated with stable 3,3	-diaminobenzidine tetra-
hydrochloride (DAB, Research Genetics, Huntsville, AL) as a
peroxidase substrate and counterstained with hematoxylin.
ICAM-1 expression was carried out as described above except
the first antibody was rabbit polyclonal anti-ICAM-1 antibody
(Caltag, San Francisco, CA). The total numbers of deep brown-
stained positive vessels were counted in each hemisphere, in-
cluding the cortex and basal ganglia region. ICAM-1 vessel
counting was done manually to exclude the infiltrating cells
occasionally expressing ICAM-1.
When double-labeled fluorescent immunohistochemistry
was used, sections were incubated for 30 min with 10% donkey
serum to reduce nonspecific binding, then incubated overnight
at 4°C with the goat anti-active NFB/p65 antibody (1:200
dilution; Santa Cruz Biotechnology). After washing,
fluorescein-conjugated donkey anti-goat IgG (1:100 dilution;
Vector) was applied for 60 min at room temperature. Sections
were incubated with polyclonal rabbit anti-neuron specific eno-
lase (NSE, 1:200 dilution; Chemicon International, Temecula,
CA) antibody for 2 hr at room temperature. NSE immunore-
activity was detected using rhodamine-conjugated donkey anti-
rabbit IgG (1:100 dilution; Vector Laboratories, Burlingame,
CA) at room temperature. Double-labeled immunostaining was
evaluated using a fluorescence microscope (Nikon Microphoto-
SA) with a filter cube (excitation filter, 450–490 nm; suppres-
sion filter, 515–560 nm) for fluorescein isothiocyanate labeling
and another filter cube (excitation filter, 515–560 nm; suppres-
sion filter, 590 nm) for rhodamine. Photomicrographs for dou-
ble labeling illustrations were obtained by changing the filter
cube without altering the position or focus of the section (Gong
et al., 1998).
Nuclear Extraction and Electrophoretic Mobility Shift
Assay
The nuclear extraction and electrophoretic mobility shift
assay (EMSA) was carried out as specified by the manufacturer’s
instructions (Promega, Minneapolis, MN). After the animals
were sacrificed, the brains were removed immediately and ho-
mogenized in a microfuge tube with buffer A (10 mM HEPES,
pH 7.9, 10 mM KCl, 1.5 mM MgCl2, 0.5 mM dithiothreitol
[DTT], 1 mM AEBSF, and 10 g/ml leupeptin). The nuclei
were collected by centrifugation at 500  g for 10 min and
washed once with buffer A containing 0.2% NP-40. The nu-
clear proteins were then extracted with buffer B (20 mM
HEPES, pH 7.9, 0.42 mM NaCl, 20% glycerol, 1 mM EDTA,
1 mM DTT, 1 mM AEBSF, and 10 g/ml leupeptin) for
30 min at 4°C, and microfuged for 30 min. The nuclear extracts
were microdialyzed against buffer C (20 mM HEPES, pH 7.9,
20% glycerol, 100 mM KCl, 0.2 mM EDTA, 0.5 mM DTT,
0.5 mM AEBSF) with an ultrafree centrifugal filter (Millipore)
and frozen at 80°C. For determination of protein-DNA in-
teractions, a double-stranded oligonucleotide containing NFB
consensus binding sequence (5	-AGT TGA GGG GAC TTT
CCC AGG C-3	) was used (Promega) and end-labeled with
gamma [32P]-ATP according to manufacturer’s recommenda-
tion. The NFB binding reactions were carried out in a final
volume of 20 l mixtures containing buffer (10 mM HEPES,
pH 7.5, 0.25 g/l poly [dI/dC], 0.1 mM NaCl, 0.8 mM
EDTA, 1 mM DTT, 0.05% NP-40, 4% glycerol), 10 g nuclear
proteins, and 106 cpm of radiolabeled probe. The mixtures were
incubated for 20 min at room temperature. The DNA-protein
complexes were resolved on a 5% nondenaturing polyacryl-
amide gel in 0.5 Tris-borate/EDTA buffer. The gel was dried
and exposed to Kodak X-ray film overnight at 70°C. EMSA
was carried out on nuclear extracts from each sample after
ischemia. Semiquantitation of the EMSA was carried out with
densitometry.
Statistical Analysis
Microcomputer based statistical programs (Statview II;
ABACUS, Berkeley, CA and Excel; Microsoft, Redmond,
WA) were used. All data are presented as mean 
 SD. Para-
metric data at different points during MCAO between the ICE
KO and the WT mice were compared using ANOVA followed




ICE KO and WT mice developed normally with no
visible neurological deficit detected in either group. The
blood pressure, blood gases, and body temperature
changes were similar and there were no statistical differ-
ences between the ICE KO and the WT mice at 0.5, 2, 4,
8, and 24 hr after MCAO (data not shown). Surface CBF
dropped sharply to below 20% of baseline in the ischemic
core, and to 35–50% of baseline in the ipsilateral perifocal
region. CBF was maintained at approximately 100% of
baseline in the contralateral hemisphere after MCAO in
both ICE KO and WT mice. There were no statistical
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differences between the two groups (P  0.05, data not
shown).
Phospho-P65/NFB Is Decreased in ICE KO Mice
After Ischemia
The levels of phospho-p65/NFB were measured
using Western blot analysis in mouse brain samples col-
lected from both ICE KO and WT mice that underwent
0.5, 2, 4, 8, and 24 hr of MCAO. Phospho-p65/NFB
was expressed at a very low level in the sham animals or in
the contralateral hemisphere of mouse brain after MCAO
(data not shown). The phospho-p65/NFB expression in
the ischemic hemisphere, however, shown as a major band
at approximately 65 kDa, increased as early as 0.5 hr of
MCAO, peaked at 2 and 4 hr, and then decreased grad-
ually in the WT mice (Fig. 1A, as a representative exper-
iment). Interestingly, phospho-p65/NFB expression was
reduced significantly in ICE KO mice after 2 and 4 hr of
MCAO compared to WT mice (P  0.05). Densitometric
quantitative data (n  4 at each time) is shown in Figure
1B. Phospho-p65/NFB expression was reduced signifi-
cantly after 2 and 4 hr of MCAO in ICE KO mice,
demonstrating that ICE or IL-1 is critical to the process of
phosphorylation of NFB during cerebral ischemia.
Cellular Localization of Phospho-p65/NFB
Localization of phospho-p65/NFB during ischemia
was assessed by immunostaining brain sections prepared
from both the ICE KO and the WT mice that underwent
MCAO for different lengths of time. As shown in Figure
2, few phospho-p65/NFB-positive cells could be de-
tected in brain sections from sham-operated mice or in the
contralateral hemisphere in ischemic mice (Fig. 2A,F).
Phospho-p65/NFB-positive cells could be detected,
however, in both the ischemic cortex and the caudate
putamen after 2 hr of MCAO (Fig. 2C,H). The regions of
p65/NFB-positive cells extended to the perifocal region
at 4 hr of MCAO (Fig. 2E,J) in the WT mice. These
results correlated with the result from Western blot anal-
ysis. The increase of phospho-p65/NFB immunoreac-
tivity was greatly attenuated, however, in both the isch-
emic cortex and the caudate putamen in ICE KO mice
(2 hr of MCAO: Fig. 2A,G; 4 hr of MCAO: Fig.2D,I).
No immunoreactivity was detected in the negative control
sections (data not shown). Further study showed that the
phospho-p65/NFB was located mainly in cytoplasm af-
ter 2 hr of MCAO (Fig. 3C), and translocated into the
nucleus after 4 hr of MCAO (Fig. 3D). Double-labeled
immunohistochemical studies revealed that early expres-
sion of p65/NFB was colocalized with NSE, a neuron
specific marker (Fig. 4). Phospho-p65/NFB-positive
cells appeared in both the ischemic cortex and the caudate
putamen after 2 hr of MCAO in WT mice. These results
demonstrate that p65/NFB was phosphorylated during
the early acute ischemic period and early phospho-p65/
NFB expression was detected mainly in the neurons.
NFB DNA Binding Activity
After release from IB, NFB translocates into the
nucleus when it binds to its consensus sequence and trans-
activates target genes. We next examined NFB DNA-
binding activity by EMSA using samples from the isch-
emic brain tissue in both the ICE KO and the WT mice.
Relative intensities of protein-DNA complex increased
after 4 hr of MCAO and remained elevated during 24 hr
of MCAO in the WT mice (Fig. 5). This correlates with
the immunostaining data showing p65/ NFB transloca-
tion into the nucleus; however, there is no significant
induction of NFB DNA binding after 4 hr of MCAO in
ICE KO mice (P  0.05, Fig. 5). This data indicates that
Fig. 1. Increase of p65/NFB activation in mouse brain after ischemia. A: Activated p65/NFB
expression during ischemia in WT and ICE KO mouse brain. Cytoplasmic protein extracts were
prepared from the ischemic hemisphere in mouse brain after 0.5, 2, 4, 8, and 24 hr of MCAO; shows
a 65-kD active NFB band detected by Western blot analysis with a polyclonal anti-active p65/NFB
antibody in a representative experiment. C, sham control animals. An equal amount of extract protein
was used in each sample (see -actin). B: The bar graph shows densitometric quantity of the
p65/NFB induction during cerebral ischemia in ICE KO and WT mice. C, sham control animals.
Values are mean 
 SD; n  4 for each time. *P  0.01, relative density of activated p65/NFB in
ICE KO mice vs. that in WT mice.
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Fig. 2. Localization of p65/NFB activation in mouse brain after ischemia. Photomicrographs
showed that active p65/NFB-positive staining in the ICK KO (left column) and the WT mice (right
column) after 2 (B,C,G,H) and 4 hr (D,E,I J) of MCAO in the ischemic cortex (B,D,G,I) and
caudate putamen (C,E,H,J), respectively. Cont, negative control section (blocking peptide): showed
no positive staining in either the ischemic cortex or caudate putamen. CTX, cortex; Cp, caudate
putamen; 2h, 2 hr of MCAO; 4h, 4 hr of MCAO. Arrowheads indicate these dark brown cells are
phospho-p65/NFB-positive cells. Many phospho-p65/NFB-positive cells in both cortex and
caudate putamen regions were detected in WT mice after 2 and 4 hr of MCAO; however,
ischemia-induced p65/NFB phosphorylation was greatly attenuated in ICE KO mice at the same
points. Scale bar  100 m.
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NFB was phosphorylated after cerebral ischemia in WT
mice, but this ischemia-induced NFB phosphorylation
was inhibited significantly in the ICE-deficient mice.
ICAM-1 Immunostaining
One known NFB target gene involved in inflam-
matory regulation is ICAM-1. Therefore, we examined
the expression of ICAM-1 in WT and ICE KO mice.
Results showed that ICAM-1-positive vessels in the ipsi-
lateral hemisphere of ICE KO mice were fewer than those
in the WT mice after 24 hr of MCAO (148 
 29 vs.
247 
 25; P  0.05). As shown in Figure 6, ICAM-1
expression in the ischemic hemisphere after 24 hr of
MCAO was increased in the WT mice; however, the
increase of ICAM-1-positive vessels in the ICE KO mice
was significantly decreased. The negative control section
showed no ICAM-1-positive staining (data not shown).
Few ICAM-1-positive vessels were detected in the isch-
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DISCUSSION
This study demonstrates that the NFB is phosphor-
ylated in WT mice at the early stage of focal cerebral
ischemia. This early NFB phosphorylation is localized in
neurons in the ischemic core and perifocal regions; how-
ever, NFB phosphorylation is greatly reduced in ICE
KO mice. Reduced ICAM-1 production, a NFB target
gene protein in the ICE KO mice, may be due to the
reduction of NFB phosphorylation. These findings sug-
gest that the mature IL-1 and ICE genes may be impor-
tant mediators of NFB phosphorylation during early
ischemia. Considerable evidence points to ICAM-1 as
crucial mediator of ischemic brain damage. Thus, reduc-
tion of early NFB phosphorylation may be one of the
mechanisms through which ICE KO mice are protected
from damaging inflammatory responses during focal cere-
bral ischemia.
Gene knockout mice provide useful tools for defin-
ing signaling pathways leading to ischemia-induced neu-
ronal death (Huang et al., 1994; Yang et al., 1994). In a
previous study, we demonstrated that after permanent
focal ischemia, ICE KO mice had less brain edema and
smaller infarction compared to WT controls (Schielke et
al., 1998). A possible mechanism underlying this observa-
tion is reduced mature IL-1 production by the ischemic
brain. ICE is a member of the caspase family of cysteine
proteases, which are associated with both proinflammatory
and apoptotic actions (Dinarello, 1992, 1996; Hara et al.,
1997a;Yang et al., 1999a). ICE is critical for processing
pro-IL-1 to the biologically active form of the cytokine,
IL-1. Previous studies have demonstrated that macro-
phages isolated from the ICE KO mice are not capable of
producing IL-1. Similarly, in a model of endotoxic
shock, no IL-1 is detected in the plasma of the ICE KO
mice, and survival is greatly enhanced. Interestingly, IL-1
production is reduced also in these mice, although not to
the extent of IL-1(Dinarello, 1997a). The possibility of
differences, however, in the genetic background of the
knockout mice and their wild-type controls is a limitation
in the use of gene knockout models. The ICE KO and
WT mice used in this study were derived from the same
progenitors, a mixed SV/129 and C57BL/6 background.
Previous observations found that these ICE KO and WT
mice developed normally (Schielke et al., 1998). Addi-
tionally, our data demonstrated that the changes in phys-
iological parameters, cortical cerebral blood flow and body
temperature, in response to MCAO, were similar in the
two groups. Thus, the resistance to ischemia induced brain
damage and activation of the NFB pathways in the ICE
KO mice is likely due to deletion of the ICE gene and not
the differences in the genetic background of the KO and
WT mice.
NFB phosphorylation has been associated with im-
mune and inflammatory responses. It is activated by a
variety of stimuli known to occur in focal ischemia, such
as cytokines, ROS, and glutamate (Baeuerle and Henkel,
1994). Expression of NFB has been described in a variety
of brain cell types, such as murine primary astrocytes,
microglia, Schwann cells, neurons, and human endothelial
cells (O’Neill and Kaltschmidt, 1997; Howard et al.,
1998). NFB activates the transcription of many genes
thought to be involved in the pathogenesis of cerebral
ischemia, including IL-1, TNF, iNOS, VCAM,
ICAM-1, and IL-6. Thus, as a signaling molecule, NFB
may play a central role in the regulation of inflammatory
responses to brain injury and infection. Existing evidence
supports this concept. For example, Salminen et al. (1995)
reported that NFB was increased significantly in the
Š
Fig. 3. Activation of p65/NFB in both cytoplasm and nucleus. Mi-
crophotographs showing DAB-positive staining for phospho-p65/
NFB in the mouse brain after 2 (C) and 4 hr (D) of MCAO. Arrows
indicated no active p65/NFB-positive cells were observed in the sham
animal (A). Active p65/NFB-positive staining could be observed after
2 hr of MCAO and these cells displayed neuronal morphology (B;
arrow indicates neuronal cell body and axons). Active p65/NFB-
positive staining located in cytoplasm after 2 hr of MCAO in the WT
mice (C), and active p65/NFB-positive staining translocated into the
nucleus after 4 hr of MCAO in the WT mice (D). This result dem-
onstrates that early p65 phosphorylation and translocation occurs in the
ischemic cells. Scale bar  20 m.
Fig. 4. Activation of p65/NFB in neurons. Double-labeling fluores-
cence photomicrographs from the ipsilateral cortex showing double-
labeled staining for p65/NFB (green; A,D) and NSE (red; B,E);
p65/NFB was well colocalized with NSE staining, demonstrating that
neurons express p65/NFB after MCAO (C,F). Neurons that are
p65/NFB-positive are detected in both ischemic cortex (A,B) and
caudate putamen (D,E). Injured neurons in the ischemic hemisphere
after 2 hr of MCAO displayed strong active p65/NFB immunoreac-
tivity, indicating that the early NFB activation occurs in the neuronal
cells after ischemic insult. Arrows point to injured cells, showing
shrunken cell bodies. Scale bar  10 m.
Fig. 5. DNA binding of NFB after MCAO. Nuclear extraction and
electrophoretic mobility shift assay (EMSA) of nuclear protein extracts
from ischemic brain tissue, probed with 32P, labeled the double-
stranded oligonucleotide containing the NFB-specific binding se-
quence (5	-AGT TGA GGG GAC TTT CCC AGG C-3	). NFB
binding reactions were carried out in a final volume of 20 l mixture
containing buffer, 10 g nuclear proteins, and 106 cpm of radiolabeled
probe. NFB indicates the bands of specific DNA-protein complexes.
The binding corresponding to active NFB is detected in both the ICE
KO and the WT mice after 0.5, 2, 4, 8, and 24 hr of MCAO. This
binding is largely reduced after 4, 8, and 24 hr of MCAO in ICE KO
mice compared to WT mice. C, positive control.
Fig. 6. Attenuation of ICAM-1 expression in ICE KO mice. Photo-
graphs showing ICAM-1-positive vessel staining in the ischemic peri-
focal areas in ICE KO (C,E) and the WT (D, F) mice after 24 hr of
MCAO. (A) shows the area examined, and (B) shows there are no
ICAM-1-positive vessels in the negative control section (blocking
peptide) after MCAO. The brown staining demonstrated that the
expression of ICAM-1-positive vessels increased greatly after 24 hr of
MCAO in WT mice (D) compared to ICE KO mice (C). Magnifica-
tion of squared areas in C and D are shown (E,F). Scale bar  30 m.
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ischemic cortex and hippocampus after 30 min of four-
vessel occlusion and 72 hr of reperfusion in rats. Yang et
al. (1995) confirmed that NFB expression was increased
in the ipsilateral cortex in the rat brain trauma model,
which is related to the production of IL-1 and TNF;
however, Schneider et al. (1999) reported contradictory
results: they found that infarct volume after 2 hr of isch-
emia and 20 hr of reperfusion was reduced significantly in
the NFB/p50 knockout mice (42 vs. 32 mm3). There are
several studies that demonstrate that NFB phosphoryla-
tion provided neuroprotection in vitro (Blatteis, 1988). All
these results suggest that NFB phosphorylation plays
different roles and transfers different signaling during focal
cerebral ischemia. Depending upon the severity and du-
ration of ischemia, NFB could transfer neuroprotective
or neurotoxic genes. These genes will then produce
downstream proteins that will repair or further damage
tissue.
Our data demonstrates that NFB is phosphorylated
after 2 hr of MCAO in the WT mice, and this phospho-
NFB form is located mainly in neurons in the ischemic
core and the perifocal regions. Reduction of the NFB
signal in the ischemic ICE KO mice suggests that early
processing of pro-IL-1 to its active form may be a critical
trigger for this response. We observed that cytosolic NFB
could translocate into the nucleus after 4 hr of MCAO,
and this is followed by an increase of nuclear NFB
DNA-binding activity. Because NFB phosphorylation
occurs earlier than the overexpression of cytokines
(Bruce-Keller and Mattson, 1998), NFB phosphoryla-
tion and translocation during MCAO may be the pathway
by which an extracellular signal rapidly evokes a transcrip-
tional response. Thus, as a signal molecule, NFB may
play a central role in the regulation of many inflammatory
responses during brain injury.
ICAM-1, one of the most studied adhesion mole-
cules, is located on the endothelial surface. Its leukocyte
counterpart, integrin CD11/CD18, and many others are
currently under investigation (Zhang et al., 1995; Yang et
al., 1998). A number of experimental studies have docu-
mented that E-selectin (ELAM) and P-selectin are upregu-
lated after focal cerebral ischemia in rodents (Okada et al.,
1994; Wang et al., 1994, 1995; Jander et al., 1995; Zhang
et al., 1995, 1996). There is considerable evidence sup-
porting the idea that leukocyte infiltration into the brain
contributes to the development of ischemic lesions.
Blocking ICAM-1 with an antibody reduces both neutro-
phil accumulation and the size of the lesion (Zhang et al.,
1994). The possible relevance of adhesion molecules in the
pathogenesis of ischemic brain damage has been demon-
strated recently, and mice deficient in the ICAM-1 gene
show a marked reduction in cerebral infarction lesions
after tMCAO (Connolly et al., 1996; Soriano et al., 1996).
ICAM-1 expression is greatly increased in hypoxic endo-
thelial cells in the presence of circulating endotoxin; how-
ever, pretreatment with salicylate, a novel NFB inhibi-
tor, completely abolishes the enhanced ICAM-1
expression (Zund et al., 1998). This study supports that
salicylate administered before cardiopulmonary bypass
may protect the heart against ischemia/reperfusion injuries
and reduce the load of the overall inflammatory response
(Zund et al., 1998). Proinflammatory cytokines IL-1 and
TNF are known to be induced earlier than the adhesion
molecules (Wang and Feuerstein, 1995). IL-1 and TNF
can upregulate the expression of ICAM-1, ELAM-1, and
P-selectin in vitro (Feuerstein et al., 1997; Yang et al.,
1999a,b). The development of the inflammatory response
in focal ischemia, therefore, may appear in the following
sequence: expression of IL-1 and TNF, upregulation of
adhesion molecules, and then migration of leukocytes. In
our study, however, the expression of ICAM-1 protein is
significantly lower in ICE KO mice compared to that in
WT mice after MCAO. This result suggests that mature
IL-1 is a critical mediator in the upregulation of ICAM-1
expression during cerebral ischemia.
In summary, we have demonstrated that NFB is
phosphorylated and translocated to the nucleus after per-
manent MCAO in WT mice but significantly reduced in
ICE KO mice, suggesting that NFB phosphorylation and
translocation during focal cerebral ischemia may depend
partially on the existence of mature IL-1 or ICE. Com-
pared to WT mice, in the ICE KO mice, ICAM-1 protein
expression during permanent MCAO was reduced signif-
icantly, suggesting that NFB may play an important role
in control and regulation of downstream genes including
the adhesion molecule ICAM-1. Because ICE is a mem-
ber of a cysteine protease family that has been implicated
in apoptotic cell death (Yuan et al., 1993), a yet to be
answered question is whether these deleterious effects are
mediated by IL-1 production or by pro-apoptotic mech-
anisms.
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